Froedtert Hospital
12
4
5
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
16.7%
2 terminated/withdrawn out of 12 trials
60.0%
-26.5% vs industry average
8%
1 trials in Phase 3/4
100%
3 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Self-sampling to Optimize Anal Lesion Outcomes
Role: collaborator
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
Role: collaborator
Stimulation-based Therapy to Improve Balance in DCM
Role: collaborator
A Communication Tool to Improve Communication in the ICU
Role: collaborator
Statins In Intracerbral Hemorrhage
Role: collaborator
EMST and Swallowing in Long-Term Survivors of HNCA
Role: collaborator
EMST in Patients Undergoing CRT for HNCA
Role: collaborator
Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized Patients
Role: collaborator
Engaging Patients in Mutual Goal-Setting in Hospitalized Patients
Role: collaborator
Step-Up Intervention for Self-Management of Fatigue in Young Adults Receiving Chemotherapy
Role: collaborator
Virtual Reality Education Program to Reduce Anxiety During Radiation Therapy
Role: collaborator
The CARS Study: Communicating About Readiness (for Discharge)
Role: collaborator
All 12 trials loaded